arrow
T

Thomas Felzmann

ludwig boltzmann institute for cancer research
H指数:23
被引数:1,696

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors
2020-01-1617
OAAI
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production
2019-06-017
PREAI
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

II期胶质母细胞瘤树突状细胞疫苗(Audencel)临床试验的免疫学分析:免疫系统特征影响治疗结局,且Audencel可上调Th1相关免疫指标。

2018-12-0543
OAAI
The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis

MAPK活化激酶MK2减弱树突状细胞介导的Th1分化和自身免疫性脑脊髓炎

2015-07-1516
OAAI